Long-term Outcomes of Additional Endoscopic Treatments for Patients with Positive Lateral Margins after Endoscopic Submucosal Dissection for Early Gastric Cancer
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background/Aims: It is uncertain whether additional endoscopic treatment may be chosen over surgery in patients with positive lateral margins (pLMs) as the only non-curative factor after endoscopic submucosal dissection (ESD) for early gastric cancer (EGC). We aimed to compare the long-term outcomes of additional endoscopic treatments in such patients with those of surgery and elucidate the clinicopathological factors that could influence the treatment selection. Methods: A total of 99 patients with 101 EGC lesions undergoing additional treatment after noncurative ESD with pLMs as the only non-curative factor were analyzed. Among them, 25 (27 lesions) underwent ESD, 29 (29 lesions) underwent argon plasma coagulation (APC), and 45 (45 lesions) underwent surgery. Clinicopathological characteristics and long-term outcomes were compared. Results: Residual tumor was found in 73.6% of cases. The presence of multiple pLMs was associated with higher risk of residual tumor (p=0.046). During a median follow-up of 58.9 months, recurrent or residual lesions after additional ESD and APC were found in 4% (1/25) and 6.8% (2/29) of patients, respectively. However, all were completely cured with surgery or repeated ESD. There were no extragastric recurrences after additional endoscopic treatment. Lymph node metastasis was identified after additional surgery in one (2.2%) patient with an EGC showing histological heterogeneity. Conclusions: Given the favorable long-term outcomes, additional ESD or APC may be an acceptable choice for patients with pLMs as the only non-curative factor after ESD for EGC. However, clincopathological characteristics such as multiple pLMs and histological heterogeneity should be considered in the treatment selection.
Abstract
Background/Aims: It is uncertain whether additional endoscopic treatment may be chosen over surgery in patients with positive lateral margins (pLMs) as the only non-curative factor after endoscopic submucosal dissection (ESD) for early gastric cancer (EGC). We aimed to compare the long-term outcomes of additional endoscopic treatments in such patients with those of surgery and elucidate the clinicopathological factors that could influence the treatment selection. Methods: A total of 99 patients with 101 EGC lesions undergoing additional treatment after noncurative ESD with pLMs as the only non-curative factor were analyzed. Among them, 25 (27 lesions) underwent ESD, 29 (29 lesions) underwent argon plasma coagulation (APC), and 45 (45 lesions) underwent surgery. Clinicopathological characteristics and long-term outcomes were compared. Results: Residual tumor was found in 73.6% of cases. The presence of multiple pLMs was associated with higher risk of residual tumor (p=0.046). During a median follow-up of 58.9 months, recurrent or residual lesions after additional ESD and APC were found in 4% (1/25) and 6.8% (2/29) of patients, respectively. However, all were completely cured with surgery or repeated ESD. There were no extragastric recurrences after additional endoscopic treatment. Lymph node metastasis was identified after additional surgery in one (2.2%) patient with an EGC showing histological heterogeneity. Conclusions: Given the favorable long-term outcomes, additional ESD or APC may be an acceptable choice for patients with pLMs as the only non-curative factor after ESD for EGC. However, clincopathological characteristics such as multiple pLMs and histological heterogeneity should be considered in the treatment selection.
참고문헌 (31)
- 김우호, "위암 병리보고서 기재사항 표준화", Journal of Pathology and Translational Medicine, 39(2), pp.106~113 (2005), 대한병리학회
- Japanese Gastric Cancer Association, "Japanese gastric cancer treatment guidelines 2014(ver. 4)", Gastric Cancer, 20, pp.1~19 (2017)
- Oda I, "Treatment strategy after non-curative endoscopic resection of early gastric cancer", Br J Surg, 95, pp.1495~1500 (2008)
- Kim HW, "Additive endoscopic resection may be sufficient for patients with a positive lateral margin after endoscopic resection of early gastric cancer", Gastrointest Endosc, 86, pp.849~856 (2017)
- Kim TS, "Endoscopic submucosal dissection for papillary adenocarcinoma of the stomach : low curative resection rate but favorable long-term outcomes after curative resection", Gastric Cancer, 22, pp.363~368 (2019)
- Min BH, "Lymphovascular invasion and lymph node metastasis rates in papillary adenocarcinoma of the stomach : implications for endoscopic resection", Gastric Cancer, 21, pp.680~688 (2018)
- Sekiguchi M, "Clinical significance of a papillary adenocarcinoma component in early gastric cancer : a single-center retrospective analysis of 628 surgically resected early gastric cancers", J Gastroenterol, 50, pp.424~434 (2015)
- Lauwers GY, "WHO Classification of Tumours of the Digestive System", pp.48~58 (2010), IARC Press
- Charlson ME, "A new method of classifying prognostic comorbidity in longitudinal studies : development and validation", J Chronic Dis, 40, pp.373~383 (1987)
- Min BH, "Surveillance strategy based on the incidence and patterns of recurrence after curative endoscopic submucosal dissection for early gastric cancer", Endoscopy, 47, pp.784~793 (2015)
- Pyo JH, "Long-term outcome of endoscopic resection vs. surgery for early gastric cancer : a noninferiority-matched cohort study", Am J Gastroenterol, 111, pp.240~249 (2016)
- Bae SY, "Early additional endoscopic submucosal dissection in patients with positive lateral resection margins after initial endoscopic submucosal dissection for early gastric cancer", Gastrointest Endosc, 75, pp.432~436 (2012)
- Ahn JY, "Clinical outcomes of argon plasma coagulation for the treatment of gastric neoplasm", Surg Endosc, 27, pp.3146~3152 (2013)
- Jung H, "Surgical outcome after incomplete endoscopic submucosal dissection of gastric cancer", Br J Surg, 98, pp.73~78 (2011)
- Yoon H, "Risk factors of residual or recurrent tumor in patients with a tumor-positive resection margin after endoscopic resection of early gastric cancer", Surg Endosc, 27, pp.1561~1568 (2013)
- Takenaka R, "Risk factors associated with local recurrence of early gastric cancers after endoscopic submucosal dissection", Gastrointest Endosc, 68, pp.887~894 (2008)
- Sekiguchi M, "Risk of recurrent gastric cancer after endoscopic resection with a positive lateral margin", Endoscopy, 46, pp.273~278 (2014)
- Jeon MY, "Longterm outcomes after noncurative endoscopic resection of early gastric cancer : the optimal time for additional endoscopic treatment", Gastrointest Endosc, 87, pp.1003~1013 (2018)
- Hwang JJ, "A scoring system for patients with a tumor-positive lateral resection margin after endoscopic resection of early gastric cancer", Surg Endosc, 30, pp.2751~2758 (2016)
- Min BH, "Endoscopic resection for undifferentiated early gastric cancer : focusing on histologic discrepancies between forceps biopsy-based and endoscopic resection specimen-based diagnosis", Dig Dis Sci, 59, pp.2536~2543 (2014)
- Kim TK, "Risk factors for local recurrence in patients with positive lateral resection margins after endoscopic submucosal dissection for early gastric cancer", Surg Endosc, 29, pp.2891~2898 (2015)
- Sagawa T, "Argon plasma coagulation for successful treatment of early gastric cancer with intramucosal invasion", Gut, 52, pp.334~339 (2003)
- Tomita T, "Outcomes of treatment of argon plasma coagulation therapy in elderly or high-risk patients with early gastric cancer : a comparison of outcomes among experienced and nonexperienced endoscopists", J Clin Gastroenterol, 45, pp.e54~e59 (2011)
- 김규영, "Clinical Outcomes of Argon Plasma Coagulation Therapy for Early Gastric Neoplasms", Clinical Endoscopy, 48(2), pp.147~151 (2015), 대한소화기내시경학회
- Kitamura T, "Argon plasma coagulation for early gastric cancer : technique and outcome", Gastrointest Endosc, 63, pp.48~54 (2006)
- Min BH, "Outcomes of endoscopic submucosal dissection for differentiated-type early gastric cancer with histological heterogeneity", Gastric Cancer, 18, pp.618~626 (2015)
- Kim TS, "Favorable long-term outcomes of endoscopic submucosal dissection for differentiated-type-predominant early gastric cancer with histological heterogeneity", J Clin Med, 9, pp.1064~ (2020)
- Lee JH, "Clinicopathological factors of multiple lateral margin involvement after endoscopic submucosal dissection for early gastric cancer", Surg Endosc, 29, pp.3460~3468 (2015)
- Hoteya S, "Secondary endoscopic submucosal dissection for residual or recurrent tumors after gastric endoscopic submucosal dissection", Gastric Cancer, 17, pp.697~702 (2014)
- Jeong JY, "Does submucosal fibrosis affect the results of endoscopic submucosal dissection of early gastric tumors?", Gastrointest Endosc, 76, pp.59~66 (2012)
- Higashimaya M, "Endoscopic submucosal dissection for residual early gastric cancer after endoscopic submucosal dissection", Gastrointest Endosc, 77, pp.298~302 (2013)